The Tennessee Ambulance Service Association (TASA) has named Vanderbilt LifeFlight’s Tim Bell the Larry Griffin Paramedic of the Year.

James Allison, PhD, whose work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” will deliver the next Flexner Discovery Lecture on Thursday, March 8.

Oregon Health and Sciences University’s Eric Gouaux, PhD, discussed mechanisms of signal transduction and clearance at the chemical synapses of the brain during his recent Flexner Discovery Lecture.

For the second week, the annual reputation survey for U.S. News & World Report Best Hospitals rankings is available on the Doximity website (www.doximity.com). Physicians who are board certified in one of the 16 adult or 10 pediatric specialties included in the reputation survey have until March 22 to log in to the Doximity website and vote.

Less than 20 years after it was developed, a thin, resilient sheet of carbon atoms with remarkable properties known as graphene is transforming biomedical fields as far flung as tissue engineering, neuroprosthetics and drug discovery.

Vanderbilt University Medical Center is encouraging its medical providers to stop using saline as intravenous fluid therapy for most patients, a change provoked by two companion landmark studies released Feb. 27 that are anticipated to improve survival and decrease kidney complications.

Vanderbilt University Medical Center has a new email address — @vumc.org. Many Medical Center departments received the @vumc.org email address during a pilot prior to the launch of eStar in November. Beginning on March 1, all new employees will be onboarded with the @vumc.org email address.